Trial Profile
Pioglitazone hydrochloride in PCOS women undergoing ICSI with antagonist protocol: A Multicenter Randomized Controlled Trial
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2018
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary)
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- 25 Sep 2017 New trial record